Transcranial Magnetic Stimulation (TMS) for Trigeminal Neuralgia

Status unconfirmed · Not applicable · Has a placebo group

Conditions studied: Facial Pain

In brief

The primary objective is to establish the feasibility of using TMS for COFP pain management in the interim period before surgery. This will be investigated by comparing the non-intervention group's self-reported pain to those who recieved TMS at several timepoints.

Key facts

Study ID

NCT04120129

Run by

Carilion Clinic

People needed

51

Starts

2020-08-01

Expected to finish

2021-06-01

Last updated by the study team

2020-11-13

Who can join

Age: 18 and older, up to 100. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Documented diagnosis of classic trigeminal neuralgia or persisten idiopathic facial pain
• Considered an appropriate candidate for surgical or stereotactic intervention - microvascular decompression or stereotactic radiosurgery- ( includes factors such as overall health, chronic medication, comorbidities) and patient preference
• Between ages 18-100
• Able to participate in 5 consecutive TMS treatments
• Has at least 3 weeks between pre-op visit and scheduled date of surgery
• Able to provide consent and complete online questionnaires on their own

You may not qualify if…

• Multiple Sclerosis or trauma-related etiology of facial pain (i.e. secondary facial pain)
• contraindication to TMS, per device guidelines:
• Metallic implant in or near head Implanted stimulator on or near head recent suicidal ideation history of epilepsy, stroke, or unexplained seizure
• Need for urgent/emergent surgical decompression.

Where it is running

• Institute for Orthopedics and Neurosciences — Roanoke, Virginia, United States (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.